Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes
Open Access
- 31 March 1994
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 93 (3) , 606-614
- https://doi.org/10.1016/s0091-6749(94)70072-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mechanism of Bradykinin-Induced Venodilation in HumansJournal of Cardiovascular Pharmacology, 1993
- Desensitization of β-Adrenoceptor– and Prostaglandin E1 Receptor–Mediated Human Vascular Smooth Muscle RelaxationJournal of Cardiovascular Pharmacology, 1992
- The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactionsJournal of Allergy and Clinical Immunology, 1990
- Biphasic and protracted anaphylaxisJournal of Allergy and Clinical Immunology, 1986
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986
- Prevention of Anaphylactoid Reactions after Radiographic Contrast Media Infusion by Combined Histamine H1- and H2-Receptor Antagonists: Results of a Prospective Controlled TrialInternational Archives of Allergy and Immunology, 1985
- Prophylaxis of anaphylactoid reactions to a polypeptidal plasma substitute by H1- plus H2-receptor antagonists: Synopsis of three randomized controlled trialsJournal of Molecular Medicine, 1982
- Effects of histamine on the circulatory systemJournal of Molecular Medicine, 1982
- Effects of infused histamine: Correlation of plasma histamine levels and symptomsJournal of Allergy and Clinical Immunology, 1982
- Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responsesJournal of Allergy and Clinical Immunology, 1981